关注
Dr. Ajay kher
Dr. Ajay kher
Vishwasth Clinic
在 vishwasth.com 的电子邮件经过验证 - 首页
标题
引用次数
年份
Immunological Complexity of Anti-human Leukocyte Antigen-C Donor-specific Antibodies: Therapeutic Insights from Two Cases
L Gaur, A Kher, MK Singhal
Indian Journal of Transplantation 18 (1), 87-89, 2024
2024
ABO-incompatible kidney transplantation in India: a single-center experience of first hundred cases
PK Jha, SB Bansal, A Rana, A Nandwani, A Kher, S Sethi, M Jain, ...
Indian Journal of Nephrology 32 (1), 42-46, 2022
32022
Grafalon® vs. thymoglobulin® as an induction agent in renal transplantation–A retrospective study
PK Jha, A Rana, A Kher, SB Bansal, S Sethi, A Nandwani, M Jain, ...
Indian Journal of Nephrology 31 (4), 336-340, 2021
32021
A case report of ABO and human leukocyte antigen incompatible renal transplant–Being immunologically smart
PK Jha, A Kher, V Kher
Indian Journal of Transplantation 14 (4), 346-348, 2020
12020
Prevention and therapy of AKI in Asia: a big challenge
A Kher, V Kher
Seminars in Nephrology 40 (5), 477-488, 2020
142020
ABO-incompatible kidney transplantation: Indian working group recommendations
AK Bhalla, BTA Kumar, M Chauhan, P Das, B Gandhi, U Hegde, T Jeloka, ...
Indian Journal of Transplantation 13 (4), 252-258, 2019
42019
Utility or futility of Interleukin 2 receptor antagonist (IL2RA) induction in kidney transplants—the devil is in the detail.
A Kher, V Kher
Transplant International 32 (8), 2019
22019
De novo NAD+ biosynthetic impairment in acute kidney injury in humans
A Poyan Mehr, MT Tran, KM Ralto, DE Leaf, V Washco, J Messmer, ...
Nature medicine 24 (9), 1351-1359, 2018
2982018
Anti A/B antibody titer rebound: Are we making it worse? Be aware of your intravenous immunoglobulin
A Kher, A Agarwal, P Jha, D Bansal, M Madken, AS Narula, R Khurana, ...
Indian Journal of Nephrology 28 (5), 407-409, 2018
22018
ABO-incompatible renal transplantation: The journey so far on a road less traveled
PK Jha, A Nandwani, A Kher, SB Bansal, S Sethi, R Sharma, M Jain, ...
Indian Journal of Transplantation 12 (3), 177-181, 2018
102018
Allocation based on virtual crossmatch alone: not yet ready for primetime
A Kher
American Journal of Transplantation 16 (12), 3577, 2016
42016
Dialysis outcomes in India: Preliminary results from a prospective cohort study
V Jha, O John, A Bassi, S Kotwal, R Joshi, B Essue, S Jan, M Gallagher, ...
NEPHROLOGY 21, 95-95, 2016
2016
Blindspots in HLA Antibody Testing: Recognition Is First Step to Nirvana
A Kher, P Dorwal, V Kher
AMERICAN JOURNAL OF TRANSPLANTATION 16, 272-272, 2016
2016
Pretransplant panel reactive antibody (PRA): Correlation with antecedent events and outcomes post kidney transplant
A Gadde, SB Bansal, P Jha, A Kher, R Sharma, M Jain, A Nandwani, ...
Indian Journal of Transplantation 4 (10), 113-114, 2016
2016
Optimizing twice weekly dialysis-converting two-star into five-star treatment?
A Kher, V Kher
Indian Journal of Nephrology 25 (6), 326-327, 2015
12015
Use of improved sickle for drudgery reduction in farmwomen of Gir-Somnath District of Gujarat
HS Patel, AO Kher, MK Bariya
Journal of Krishi Vigyan 3 (2s), 109-112, 2015
142015
Fever, Abdominal Pain and Renal Failure in a Kidney Transplant Recipient
A Kher, KE Raven, YB Kushner, DA Mandelbrot
American Journal of Transplantation 13 (2), 518-520, 2013
2013
Learn more about it
A Kher, J Rodrigue, M Ajaimy, M Wasilewski, K Ladin, O Procurement, ...
Nursing made Incredibly Easy, 2013
2013
Reimbursement for living kidney donor follow-up care: How often does donor insurance pay?
A Kher, J Rodrigue, M Ajaimy, M Wasilewski, K Ladin, D Mandelbrot
Transplantation 94 (10), 1049-1051, 2012
52012
Pre-emptive kidney transplantation to improve survival in patients with type 1 diabetes and imminent risk of ESRD
M Pavlakis, A Kher
Seminars in Nephrology 32 (5), 505-511, 2012
142012
系统目前无法执行此操作,请稍后再试。
文章 1–20